Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Male C57BL/6J mice raised on high fat diet (HFD) become prediabetic and develop insulin resistance and sensory neuropathy. The same mice given low doses of streptozotocin are a model of type 2 diabetes (T2D), developing hyperglycemia, severe insulin resistance and diabetic peripheral neuropathy involving sensory and motor neurons. Because of suggestions that increased NAD + metabolism might address glycemic control and be neuroprotective, we treated prediabetic and T2D mice with nicotinamide riboside (NR) added to HFD. NR improved glucose tolerance, reduced weight gain, liver damage and the development of hepatic steatosis in prediabetic mice while protecting against sensory neuropathy. In T2D mice, NR greatly reduced non-fasting and fasting blood glucose, weight gain and hepatic steatosis while protecting against diabetic neuropathy. The neuroprotective effect of NR could not be explained by glycemic control alone. Corneal confocal microscopy was the most sensitive measure of neurodegeneration. This assay allowed detection of the protective effect of NR on small nerve structures in living mice. Quantitative metabolomics established that hepatic NADP + and NADPH levels were significantly degraded in prediabetes and T2D but were largely protected when mice were supplemented with NR. The data justify testing of NR in human models of obesity, T2D and associated neuropathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NMN and NR demonstrated protect against diabetes, Alzheimer disease, endothelial dysfunction, and inflammation.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In hyperglycaemic mice, nicotinamide riboside administration improved liver steatosis and glucose tolerance, and reduced weight gain257.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [257]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The natural source of oral NR, NAM and NA is largely the NAD+ in the food we eat as broken down by digestion and the microbiome23.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060
Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors
Rutter, J., Reick, M., Wu, L. C., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1060698 · Cited by 1,059
NAD+ metabolism in health and disease
Belenky, P., Bogan, K. L., & Brenner, C. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.006 · Cited by 981
Self-citationDiabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Self-citationBogan, K. L., & Brenner, C. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155443 · Cited by 707
Self-citation
Cited by
Items 101–200 of 300
NAD+ Metabolism and Immune Regulation: New Approaches to Inflammatory Bowel Disease Therapies
Chen, C., Yan, W., Tao, M., & Fu, Y. (2023) · Antioxidants · doi:10.3390/antiox12061230 · Cited by 49
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Bhasin, S., Seals, D. R., Migaud, M. E., Musi, N., & Baur, J. A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad019 · Cited by 54
Dall, M., Penke, M., Sulek, K., Matz‐Soja, M., Holst, B., Garten, A., Kieß, W., & Treebak, J. T. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.01.025 · Cited by 46
Combined Metabolic Cofactor Supplementation Reduces Liver Fat in Nonalcoholic Fatty Liver Disease
Zeybel, M., Altay, Ö., Arif, M., Li, X., Yang, H., Fredolini, C., Akyıldız, M., Sağlam, B., Gönenli, M. G., Ural, D., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110459 · Cited by 44
“Two other components of CMA including carnitine and NR, which stimulate the transfer of fatty acids from the cytosol to mitochondria, are also depleted in liver diseases (Hagen et al, 1998; Bieganowski & Brenner, 2004; Trammell et al, 2016; Salic et al, 2019; Savic et al, 2020).”
BackgroundSirtuins are not conserved longevity genes
Brenner, C. (2022) · Life Metabolism · doi:10.1093/lifemeta/loac025 · Cited by 46
“…targeted NAD metabolomics 113 has revealed that the NAD system is functionally disturbed by conditions of metabolic stress including fatty liver 114 , peripheral 115 and central 116 neurodegeneration, noise-induced hearing loss 117 , DNA damage 118 , heart failure 119 , postpartum 120 ,…”
BackgroundSelf-citationMaric, T., Bazhin, A. A., Khodakivskyi, P. V., Mikhaylov, G., Solodnikova, E. S., Yevtodiyenko, A., Attianese, G. M. P. G., Coukos, G., Irving, M. B., Joffraud, M., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114826 · Cited by 45
Diabetic complications and prospective immunotherapy
Reynolds, L., Luo, Z., & Singh, K. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219598 · Cited by 51
“In tissues lacking sorbitol dehydrogenase, such as those associated with diabetic complications, research has been conducted in animal models and human cell lines (117, 118), however more research is needed into the effect on humans in vivo.”
BackgroundBalancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
Cercillieux, A., Ciarlo, E., & Cantó, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04499-5 · Cited by 42
“In agreement, NR administration prevented non-alcoholic fatty liver disease (NAFLD) [80, 84], alcohol-related liver damage [89] and diet-induced hepatic fibrosis [212].”
BackgroundCoordinated metabolic transitions and gene expression by NAD+ during adipogenesis
Sánchez-Ramírez, E., Ung, T. P. L., del Carmen, A. A., del Toro-Ríos, X., Fajardo-Orduña, G. R., Noriega, L. G., Cortés-Morales, V. A., Tovar, A. R., Montesinos, J. J., Orozco-Solís, R., et al. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202111137 · Cited by 45
Biţă, A., Scorei, I. R., Ciocîlteu, M. V., Nicolaescu, O. E., Pîrvu, A. S., Bejenaru, L. E., Rău, G., Bejenaru, C., Radu, A., Neamţu, J., et al. (2023) · Molecules · doi:10.3390/molecules28166078 · Cited by 36
“NR treatment significantly restored liver NADP+ and NADPH amounts and reduced weight gain, blood glucose and HS [166].”
BackgroundGerasimenko, M., Михайлович, Ч. С., Furuhara, K., Lopatina, O. L., Salmina, A. B., Shabalova, A. A., Tsuji, C., Yokoyama, S., Ishihara, K., Brenner, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57236-7 · Cited by 43
Self-citationThe emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism
Fletcher, R. S., & Lavery, G. G. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0085 · Cited by 38
Kourtzidis, I. A., Dolopikou, C. F., Tsiftsis, A. N., Margaritelis, N. V., Theodorou, A. A., Zervos, I. A., Tsantarliotou, M. P., Veskoukis, A. S., Vrabas, I. S., Paschalis, V., et al. (2018) · Experimental Physiology · doi:10.1113/ep086964 · Cited by 41
Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity
Dall, M., Trammell, S. A. J., Asping, M., Hassing, A. S., Agerholm, M., Vienberg, S. G., Gillum, M. P., Larsen, S., & Treebak, J. T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006756 · Cited by 45
“NAD precursor supplementation has also been shown to efficiently improve mitochondrial function in multiple organs and cell types (9, 11–15), and it has been used to treat rodent models of type 2 diabetes (16, 17).”
MethodSelf-citationZhang, X., Zhang, N., Chrenek, M. A., Girardot, P. E., Wang, J., Sellers, J. T., Geisert, E. E., Brenner, C., Nickerson, J. M., Boatright, J. H., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060893 · Cited by 40
Self-citationDiscovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors
Wilsbacher, J. L., Cheng, M., Cheng, D., Trammell, S. A. J., Shi, Y., Guo, J. Q., Koeniger, S. L., Kovar, P. J., He, Y., Selvaraju, S., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0819 · Cited by 39
“NADþ metabolome analysis NADþ and related metabolites were analyzed as described previously (39, 40).”
MethodSelf-citationChandrasekaran, K., Najimi, N., Sagi, A. R., Yarlagadda, S., Salimian, M., Arvas, M. I., Hedayat, A. F., Kevas, Y., Kadakia, A., & Russell, J. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094887 · Cited by 40
“In addition to hyperglycemia, dyslipidemia has been suggested as a major contributor to DPN in T2D (reviewed in [3–5]).”
BackgroundInfluentialCurrent Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
Poljšak, B., Kovač, V., & Milisav, I. (2022) · Antioxidants · doi:10.3390/antiox11091637 · Cited by 52
“Their increase were reported upon the NR supplementation [118,159].”
BackgroundShi, W., Hegeman, M. A., Doncheva, A., Bekkenkamp-Grovenstein, M., de Boer, V. C. J., & Keijer, J. (2019) · Nutrients · doi:10.3390/nu11102439 · Cited by 37
“Since dietary NR was shown in multiple animal studies to improve metabolic health [3,5,11,12], but also was shown to either have no effect [26] or have detrimental effects depending on the dose and animal model used [19–21], we analyzed the long-term (18 weeks) metabolic health effects of dietary high doses of NR in H…”
BackgroundControl of NAD+ homeostasis by autophagic flux modulates mitochondrial and cardiac function
Zhang, Q., Li, Z., Li, Q., Trammell, S. A. J., Schmidt, M. S., Pires, K. M. P., Cai, J., Zhang, Y., Kenny, H., Boudina, S., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-023-00009-w · Cited by 40
“The NAD + levels and its related metabolites were measured using LC-MS methods as described in previous studies (Trammell et al, 2016a, 2016b).”
InfluentialSelf-citationZhang, M., Du, W., Acklin, S., Jin, S., & Xia, F. (2020) · Journal of Clinical Investigation · doi:10.1172/jci123159 · Cited by 41
“Interestingly, nicotinamide riboside, a precursor of NAD+ and activator of SIRT1 and SIRT2, has been shown to alleviate paclitaxel-induced peripheral neuropathy independently of DNA damage repair (38).”
BackgroundInfluentialAxon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy
Coleman, M. P. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01297-6 · Cited by 33
“In connection with this, there is now a substantial literature and wider public discussion of therapy and prevention of neurological disorders using precursors of NAD, such as nicotinamide (Nam) and its riboside (NR) or mononucleotide (NMN) [114, 115, 116].”
BackgroundRole of pseudohypoxia in the pathogenesis of type 2 diabetes
Song, J., Yang, X., & Yan, L. (2019) · Hypoxia · doi:10.2147/hp.s202775 · Cited by 40
“For example, NR administration in diabetic mouse decreased fasting and nonfasting glucose levels, decreased weight gain, and lessened hepatic steatosis with concurrent protection against diabetic neuropathy.(92) In prediabetic mouse, NR could improve glucose tolerance, decrease body weight gain, prevent liver damage,…”
BackgroundWang, Z., Bao, X., Hu, J., Shen, S., Xu, G., & Wu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671563 · Cited by 36
“NR has promising characteristics for Alzheimer’s disease, insulin sensitivity, and diabetic neuropathy (Cantó et al., 2012; Trammell et al., 2016; Xie et al., 2019).”
BackgroundPeclat, T., Shi, B., Varga, J., & Chini, E. N. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000737 · Cited by 34
Uddin, G. M., Youngson, N. A., Chowdhury, S. S., Hagan, C., Sinclair, D. A., & Morris, M. J. (2020) · Cells · doi:10.3390/cells9040791 · Cited by 32
“NR supplementation in food (200–400 mg/kg, ranging from 8–18 weeks) has been shown in multiple studies with HFD fed male mice to protect against body weight gain, to improve glucose tolerance, and to reduce hepatic steatosis, [16,30], lipid accumulation, liver fibrosis [31], and hepatic ER stress [32].”
BackgroundConnell, N., Grevendonk, L., Fealy, C., Moonen-Kornips, E., Bruls, Y., Schrauwen-Hinderling, V., de Vogel, J., Hageman, R., Geurts, J., Zapata-Perez, R., et al. (2021) · The Journal of Nutrition · doi:10.1093/jn/nxab193 · Cited by 33
The Regulatory Role of NAD in Human and Animal Cells
Kulikova, V., Gromyko, D. V., & Nikiforov, A. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918070040 · Cited by 40
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
Rotllán, N., Camacho, M., Tondo, M., Diarte‐Añazco, E. M. G., Canyelles, M., Méndez‐Lara, K. A., Benítez, S., Alonso, N., Mauricio, D., Escolá‐Gil, J. C., et al. (2021) · Antioxidants · doi:10.3390/antiox10121939 · Cited by 34
El-Kady, R. R., Ali, A. K., Wakeel, L. M. E., Sabri, N. A., & Shawki, M. A. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221077958 · Cited by 34
NAD + Precursors in Human Health and Disease: Current Status and Future Prospects
Yaku, K., & Nakagawa, T. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0354 · Cited by 33
“…NR has been shown to increase levels of dea-midated NAD + metabolites such as NAR and NAAD in whole blood, PBMCs, urine, and skeletal muscle (Brakedal et al., 2022; Dollerup et al., 2018; Elhassan et al., 2019; Jensen et al., 2022; Remie et al., 2020; Stocks et al., 2021; Trammell et al., 2016a).”
InfluentialNicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome
Sun, W.-D., Zhu, X., Li, J., Mei, Y.-Z., Li, J.-H., & Li, J.-H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1410479 · Cited by 40
NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections
Klabunde, B., Wesener, A., Bertrams, W., Beinborn, I., Paczia, N., Surmann, K., Blankenburg, S., Wilhelm, J., Serranía, J., Knoops, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41372-w · Cited by 35
“To determine whether NAD + precursor NR increases the intracellular concentration of NAD + in vitro and in vivo 13 – 15 .”
Implications of NAD + boosters in translational medicine
Kang, B. E., Choi, J., Stein, S., & Ryu, D. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13334 · Cited by 34
Parker, R., Schmidt, M. S., Cain, O. L., Gunson, B. K., & Brenner, C. (2020) · Hepatology Communications · doi:10.1002/hep4.1530 · Cited by 32
“On the basis of recent data showing that NR has the highest level of hepatic oral availability of the NAD+ precursor vitamins,(25) that endogenous NR metabolism protects the liver,(29,35) and that high-dose NR is safe and potentially valuable in and fatty liver,(45) measures to increase NAD+ content in human liver mig…”
BackgroundMethodSelf-citationMetabolic syndrome exacerbates amyloid pathology in a comorbid Alzheimer's mouse model
Tyagi, A., Mirita, C., Taher, N., Shah, I., Moeller, E., Tyagi, A., Chong, T., & Pugazhenthi, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165849 · Cited by 31
“NR prevents high-fat diet-induced obesity in mice through activation of SIRT1 and SIRT3 [90] and reverses insulin resistance and glucose intolerance in a mouse model for type 2 diabetes [91].”
BackgroundPoljšak, B., Kovač, V., & Milisav, I. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8819627 · Cited by 36
Nicotinamide riboside regulates inflammation and mitochondrial markers in AML12 hepatocytes
Lee, H. J., & Yang, S. J. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.1.3 · Cited by 34
“NR supplementation prevented the development of diabetic neuropathy in a rodent model of type 2 diabetes [13].”
BackgroundRegulatory T cells promote adipocyte beiging in subcutaneous adipose tissue
Fang, W., Deng, Z., Benadjaoud, F., Yang, D., Yang, C., & Shi, G. (2020) · The FASEB Journal · doi:10.1096/fj.201902518r · Cited by 31
Song, X., Zhu, Z., Qian, X., Liu, X., Chen, S., & Tang, H. (2022) · Molecules · doi:10.3390/molecules27061904 · Cited by 30
“Niacinamide N-oxide belongs to the nicotinamides, a class of organic compounds, which can promote the production of NADP (+) and NADPH, playing a role in blood glucose control and neuroprotection [63].”
BackgroundProgress in the Pathogenesis of Diabetic Encephalopathy: The Key Role of Neuroinflammation
Luo, Y., Zhu, J., Hu, Z., Luo, W., Du, X., Hu, H., & Peng, S. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3841 · Cited by 33
“Nicotinamide riboside (NR), a NAD þ precursor and a vitamin B3 [276, 277], has been shown to have neuroprotective and cognitive‐improving effects [278, 279].”
Nicotinamide Riboside Enhances In Vitro Beta-adrenergic Brown Adipose Tissue Activity in Humans
Nascimento, E. B. M., Moonen, M. P. B., Remie, C. M. E., Gariani, K., Jörgensen, J. A., Schaart, G., Hoeks, J., Auwerx, J. H., Lichtenbelt, W. D. V. M., & Schrauwen, P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa960 · Cited by 30
Purine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells
Kropotov, A., Kulikova, V., Solovjeva, L., Yakimov, A. P., Nerinovski, K., Svetlova, M., Sudnitsyna, J. S., Plusnina, A., Antipova, M., Khodorkovskiy, M., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102615 · Cited by 31
“In particular, there are studies that showed no beneficial effects of NR supplementation (27-29), whereas clear health benefits were observed in others (3,5,30-32).”
BackgroundHan, K. K., Singh, K., Meadows, A. M., Sharma, R., Hassanzadeh, S., Wu, J., Goss-Holmes, H., Huffstutler, R. D., Teague, H., Mehta, N. N., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101157 · Cited by 36
“12 In humans, studies to date suggest that NMN may appear to have numerous beneficial effects, and a question has been posited as to whether NR may have tissue-specific rather than systemic effects.”
BackgroundChu, D., & Tao, Y. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0536-y · Cited by 29
“In a mouse model of type 2 diabetes (T2D), NR also improved glucose tolerance and reduced weight gain [25].”
BackgroundChanneling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death
Reddy, V. G., Krider, I. S., Alves, E. T. M., Courey, J. M., Laham, M. S., & Thatcher, G. R. J. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02112 · Cited by 30
Vitamin B3 forms as precursors to NAD+: Are they safe?
Poljšak, B., & Milisav, I. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.07.020 · Cited by 30
NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging
Chubanava, S., Karavaeva, I. E., Ehrlich, A. M., Justicia, R. M., Basse, A. L., Kulik, I., Dalbram, E., Ahwazi, D., Heaselgrave, S. R., Trôst, K., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.002 · Cited by 37
Zhang, X., Henneman, N. F., Girardot, P. E., Sellers, J. T., Chrenek, M. A., Li, Y., Wang, J., Brenner, C., Nickerson, J. M., & Boatright, J. H. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.10.47 · Cited by 27
Self-citationRecent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?
Kim, C.-K., Sachdev, P. S., & Braidy, N. (2022) · Aging and Disease · doi:10.14336/ad.2021.0705 · Cited by 32
“Moreover, NR demonstrated neuroprotective effects in PD mice model [182, 188].”
BackgroundNicotinamide and NAFLD: Is There Nothing New Under the Sun?
Guarino, M., & Dufour, J.-F. (2019) · Metabolites · doi:10.3390/metabo9090180 · Cited by 25
“These studies showed the powerful biological effects of NR in mitigating the negative consequences of HFDs [70,71,81,82], suggesting that NAD substrates supplementation may be a promising therapeutic strategy for preventing and treating NAFLD/NASH.”
BackgroundMoss, K. R., & Höke, A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146539 · Cited by 25
Food restriction promotes damage reduction in rat models of type 2 diabetes mellitus
da Rosa, C. V. D., de Campos, J. M., de Sá‐Nakanishi, A. B., Comar, J. F., Martins, I. P., Mathias, P. C. D. F., Pedrosa, M. M. D., de Godoi, V. A. F., & Natali, M. R. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199479 · Cited by 25
Hamity, M. V., White, S. R., Blum, C., Gibson-Corley, K. N., & Hammond, D. L. (2020) · Pain · doi:10.1097/j.pain.0000000000001924 · Cited by 27
“Unfortunately, because tumors were not obtained until the end of the study, it is not known whether the number of Ki67-positive tumor cells was also further reduced during the concomitant administration of paclitaxel and NR.”
BackgroundResultInfluentialSeldeen, K. L., Shahini, A., Thiyagarajan, R., Redae, Y. Z., Leiker, M., Rajabian, N., Dynka, A., Andreadis, S. T., & Troen, B. R. (2021) · Nutrition · doi:10.1016/j.nut.2021.111189 · Cited by 30
Emerging Role of Nicotinamide Riboside in Health and Diseases
Sharma, C., Donu, D., & Cen, Y. (2022) · Nutrients · doi:10.3390/nu14193889 · Cited by 24
“The literature is replete with the beneficial effects of NR-mediated NAD+ elevation in a broad spectrum of diseases, including neurodegenerative diseases [18,19], metabolic disorders [20,21], and cardiac fibrosis [22].”
BackgroundEscalante‐Covarrubias, Q., Mendoza-Viveros, L., González-Suárez, M., Sitten-Olea, R., Velázquez‐Villegas, L. A., Becerril-Pérez, F., Pacheco-Bernal, I., Carreño‐Vázquez, E., Sanchez, P. B. M., Bustamante-Zepeda, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37286-2 · Cited by 28
Nicotinamide Riboside-Conditioned Microbiota Deflects High-Fat Diet-Induced Weight Gain in Mice
Lozada-Fernández, V. V., deLeon, O., Kellogg, S. L., Saravia, F. L., Hadiono, M. A., Atkinson, S. N., Grobe, J. L., & Kirby, J. R. (2022) · mSystems · doi:10.1128/msystems.00230-21 · Cited by 23
“Furthermore, NR, which can be metabolized and produced by bacteria (13, 35–38), increases NAD1 levels in metabolic tissues and subsequently improves host metabolism (15, 25, 26).”
BackgroundNicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity
Cartwright, D. M., Oakey, L. A., Fletcher, R. S., Doig, C. L., Heising, S., Larner, D. P., Nasteska, D., Berry, C. E., Heaselgrave, S. R., Ludwig, C., et al. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0123 · Cited by 23
“In previous studies, NR supplementation was shown to be effective in mice with strong obesity or diabetic phenotype (Cantó et al. 2012, Trammell et al. 2016).”
InfluentialChen, Y., Yang, Z., Bai, J., Wang, X., Yuan, Q., Mi, Y., & Zhang, C. (2024) · Antioxidants · doi:10.3390/antiox13030377 · Cited by 27
“Evidence suggests that the increase in NAD + can restore hallmarks of mitochondrial dysfunction during aging, increase energy metabolism [46], and maintain glucose homeostasis [47].”
BackgroundPeluso, A. A., Lundgaard, A. T., Babaei, P., Mousovich‐Neto, F., Rocha, A. L. S., Damgaard, M. V., Bak, E. G., Gnanasekaran, T., Dollerup, O. L., Trammell, S. A. J., et al. (2023) · npj Aging · doi:10.1038/s41514-023-00106-4 · Cited by 27
Self-citationFeng, D., Xu, D., Murakoshi, N., Tajiri, K., Qin, R., Yonebayashi, S., Okabe, Y., Li, S., Yuan, Z., Aonuma, K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134655 · Cited by 23
“Moreover, Nampt was shown to suppress oxidative stress by increasing NADPH levels in cell [27,28], while NAD precursor NR supplementation partially restored diabetic-induced degradation of NADH and NADPH levels [29].”
BackgroundKim, M., Pham, T. X., vanLuling, M., Kostour, V., Kang, H., Corvino, O., Jang, H., Odell, W., Bae, M., Park, Y., et al. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109058 · Cited by 23
SIRT6 : A potential therapeutic target for diabetic cardiomyopathy
Wu, T., Qu, Y., Xu, S., Wang, Y., Liu, X., & Ma, D. (2023) · The FASEB Journal · doi:10.1096/fj.202301012r · Cited by 25
Cuny, H., Kristianto, E., Hodson, M. P., & Dunwoodie, S. L. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114409 · Cited by 24
Overexpression of NRK1 ameliorates diet- and age-induced hepatic steatosis and insulin resistance
Fan, R., Cui, J., Ren, F., Wang, Q., Huang, Y., Zhao, B., Wei, L., Qian, X., & Xiong, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.107 · Cited by 21
Purhonen, J., Rajendran, J., Tegelberg, S., Smolander, O., Pirinen, E., Kallijärvi, J., & Fellman, V. (2018) · The FASEB Journal · doi:10.1096/fj.201800090r · Cited by 26
“Pharmacological doses of NAD precursors (vitamin B3s) can replenish depleted NAD , and the administration of a novel vitaminB3, nicotinamide riboside (NR) (12), was shown to ameliorate high-fat diet–induced obesity (3),mitochondrialmyopathy (4, 5), cardiomyopathy (6), hearing loss (7), fatty liver disease (8), type 2…”
BackgroundAcklin, S., & Xia, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041975 · Cited by 22
“Activation of SIRT2 by resveratrol [76] or nicotinamide riboside, a naturally occurring vitamin precursor of NAD+ [77], has been reported to alleviate diabetic neuropathic pain in animal models [78,79].”
BackgroundGlycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency
Tiwari, V., Jin, B., Sun, O., Gonzalez, E. D. J. L., Chen, M.-H., Wu, X., Shah, H., Zhang, A., Herman, M. A., Spracklen, C. N., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01399-3 · Cited by 25
Self-citationde Castro, J. M., Assumpção, J. A. F., Stein, D. J., Ströher, R., da Silva, L. S., Caumo, W., Carraro, C. C., Araújo, A. S. D. R., & Torres, I. L. D. S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118596 · Cited by 22
Kharitonova, T. V., Shvarts, Y. G., Verbovoy, A. F., Orlova, N. S., Puzyreva, V. P., & Strokov, I. A. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002785 · Cited by 24
Zhang, Y., Zhu, W., Wang, M., Xi, P., Wang, H., & Tian, D. (2023) · IUBMB Life · doi:10.1002/iub.2707 · Cited by 20
Clinical Approaches for Mitochondrial Diseases
Hong, S., Kim, S., Kim, K., & Lee, H. (2023) · Cells · doi:10.3390/cells12202494 · Cited by 28
“NR research in mice has focused on its effects on mitochondria, showing that it increases mitochondrial function, extends the lifespan of mice, and helps retain neuropathy [155,157,158].”
BackgroundNatural Supplements for COVID19—Background, Rationale, and Clinical Trials
Hermel, M. H., Sweeney, M., Ni, Y.-M., Bonakdar, R. A., Triffon, D. W., Suhar, C. J., Mehta, S., Dalhoumi, S., & Gray, J. (2021) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x211036875 · Cited by 21
“Additionally, NAD has been associated with better glycemic control and neuroprotective effects via its involvement in catabolic pathways, and has demonstrated cardioprotective effects via lipid metabolism and relief of oxidative stress.(81,84,85) Early studies of the COVID-19 virus have revealed similar actions to oth…”
BackgroundMcGinnis, C. D., Jennings, E. Q., Harris, P. S., Galligan, J. J., & Fritz, K. S. (2022) · Cells · doi:10.3390/cells11132045 · Cited by 18
Wei, X., Wei, C., Tan, Y., Dong, X., Yang, Z., Yan, J., & Luo, X. M. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109296 · Cited by 20
Acute exercise boosts NAD+ metabolism of human peripheral blood mononuclear cells
Walzik, D., Joisten, N., Schenk, A., Trebing, S., Schaaf, K., Metcalfe, A. J., Spiliopoulou, P., Hiefner, J., McCann, A., Watzl, C., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.004 · Cited by 18
“Alterations in cellular NAD ⁺ homeostasis are a common feature of numerous conditions of metabolic stress (9, 10) , including DNA damage (11) , central (12) and peripheral neurodegeneration (13) , heart failure (14) , fatty liver disease (15) , and viral infection (16) .”
Self-citationProkopidis, K., Moriarty, F., Bahat, G., McLean, J., Church, D. D., & Patel, H. P. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13799 · Cited by 25
“Specifically, these compounds may aid in restoring NAD + levels, promoting improved mitochondrial function [20, 21] and glucose profile [22, 23].”
Nicotinic acid riboside maintains NAD+ homeostasis and ameliorates aging-associated NAD+ decline
Song, W.-S., Shen, X., Du, K., Ramirez, C. B., Park, S. H., Cao, Y., Le, J., Bae, H., Kim, J., Chun, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.007 · Cited by 23
SIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure
Buonvicino, D., Ranieri, G., Pittelli, M. G., Lapucci, A., Bragliola, S., & Chiarugi, A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100855 · Cited by 17
“large body of evidence shows that impairment of NAD+ availability, due to either reduced biosynthesis or increased consumption, promotes aging (3, 4), diabetes (5), obesity (6), and neurodegeneration (7).”
BackgroundTyagi, A., Musa, M., Labeikovsky, W., & Pugazhenthi, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-23652-5 · Cited by 20
OʼBrien, J., Niehaus, P., Chang, K., Remark, J., Barrett, J., Dasgupta, A., Adenegan, M., Salimian, M., Kevas, Y., Chandrasekaran, K., et al. (2024) · Brain · doi:10.1093/brain/awae100 · Cited by 20
Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection
Dash, S., Dash, C., & Pandhare, J. (2021) · Non-Coding RNA · doi:10.3390/ncrna7040060 · Cited by 19
“It is well established that metabolic stresses, including obesity, type 2 diabetes [36], smoking [37], heart failure [38], hypertension [39], nerve damage [40], and brain injury [41], deplete intracellular ATP and NAD+ in affected tissues with a dramatic induction of ROS and PARP-1 expression.”
BackgroundWilliams, A. S., Koves, T. R., Pettway, Y. D., Draper, J. A., Slentz, D. H., Grimsrud, P. A., Ilkayeva, O., & Muoio, D. M. (2021) · iScience · doi:10.1016/j.isci.2021.103635 · Cited by 17
Nicotinamide riboside has protective effects in a rat model of mesenteric ischaemia‐reperfusion
Toropova, Y. G., Печникова, Н. А., Александровна, З. И., Zhuravsky, S. G., Kornyushin, O. V., Gonchar, A. I., Ivkin, D. Y., Leonova, Y. V., Karev, V. E., & Karabak, I. A. (2018) · International Journal of Experimental Pathology · doi:10.1111/iep.12302 · Cited by 15
Takaso, Y., Noda, M., Hattori, T., Roboon, J., Hatano, M., Sugimoto, H., Brenner, C., Yamamoto, Y., Okamoto, H., Higashida, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73984-3 · Cited by 17
Self-citationSerrano, A., Palou, A., Bonet, M. L., & Ribot, J. (2022) · Nutrients · doi:10.3390/nu14112259 · Cited by 19
The Roles of White Adipose Tissue and Liver NADPH in Dietary Restriction-Induced Longevity
Jamerson, L. E., & Bradshaw, P. C. (2024) · Antioxidants · doi:10.3390/antiox13070820 · Cited by 23
Luo, C., Yang, C., Wang, X., Chen, Y., Liu, X., & Deng, H. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109056 · Cited by 18
Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent mannerPreprint
Kane, A. E., Chellappa, K., Schultz, M. B., Arnold, M. W., Li, J., Amorim, J., Diener, C., Zhu, D., Mitchell, S. J., Griffin, P. T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.21.599604 · Cited by 16
Lu, X., Yang, R., Chen, Y., & Chen, D. (2024) · iScience · doi:10.1016/j.isci.2024.109174 · Cited by 16
Pharmacological interventions in human aging
Petr, M. A., Matiyevskaya, F., Osborne, B., Berglind, M., Reves, S., Zhang, B., Ezra, M. B., Carmona-Marin, L. M., Syadzha, M. F., Mediavilla, M. C., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102213 · Cited by 21
Gallagher, C., & Emmanuel, O. O. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103057 · Cited by 19
Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms
Torres-Méndez, J. K., Niño-Narvión, J., Martinez-Santos, P., Diarte‐Añazco, E. M. G., Méndez‐Lara, K. A., del Olmo, T. V., Rotllán, N., Julián, M. T., Alonso, N., Mauricio, D., et al. (2023) · Nutrients · doi:10.3390/nu15143083 · Cited by 15
“…brain inflammation has been strongly linked to nerve tissue NAD+ As such, NAD+ replenishment is emerging as a potential therapy to combat the development of neurological manifestations in diabetic subjects [21]. depletion in different scenarios [19,31,32], including insulin-deficient states [21].”
Redeuil, K. M., Vulcano, J., Prencipe, F. P., Bénet, S., Campos-Giménez, E., & Meschiari, M. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.01.028 · Cited by 17
Podyacheva, E., & Toropova, Y. G. (2021) · Nutrients · doi:10.3390/nu13103435 · Cited by 17
“[99] C57BL/6J mice, male 500 mg/kg 6 days IP Improved glucose tolerance; reduced weight gain, liver damage and the development of hepatic steatosis in prediabetic mice; protect against sensory neuropathy”
BackgroundSirtuin1 in vascular endothelial function, an overview
Kumar, J., & Kumar, S. (2021) · Epigenetics · doi:10.1080/15592294.2021.1975936 · Cited by 14
Beirowski, B. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105751 · Cited by 16
Shoji, M., Kato, H., Koshizaka, M., Kaneko, H., Baba, Y., Ishikawa, T., Teramoto, N., Kinoshita, D., Yamaguchi, A., Maeda, Y., et al. (2025) · Aging Cell · doi:10.1111/acel.70093 · Cited by 18
“While NR has been shown to elevate NAD + levels in human blood within hours (Trammell et al. 2016b), a previous crossover study reported an anti-inflammatory effect of NR following a 21-day administration period with a subsequent 2–3 week washout phase (Elhassan et al. 2019).”
The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma
Silva, S. G. N. E., Occhiutto, M. L., & Costa, V. P. (2023) · European Journal of Ophthalmology · doi:10.1177/11206721231161101 · Cited by 14
Metadata
- Authors
- Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C.
- Affiliations
- University of Iowa (US)
- Iowa City VA Health Care System (US)
- Corresponding author
- Brenner, Charles
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-05-27
- Volume
- 6
- Issue
- 1
- Pages
- 26933-26933
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4882590
- OpenAlex
- W2400466055
- Cited by
- 301
- References
- 36
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 55 · 2021: 42 · 2020: 33 · 2019: 34 · 2018: 25 · 2017: 20 · 2016: 4
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
- Funders
- U.S. Department of Veterans Affairs (I01 BX001680, BX001680-01, BX001680, RX000889, C9251-C, RX000889-01, I01 RX000889)
- Roy J. Carver Charitable Trust
- Fraternal Order of Eagles
- National Institutes of Health (BX001680)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Institute of General Medical Sciences (T32GM008629)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081147)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Keywords
- nicotinamide riboside, type 2 diabetes, diabetic neuropathy, NAD+ metabolism, insulin resistance, high-fat diet, streptozotocin-induced diabetes, hepatic steatosis, glucose tolerance, sensory neuropathy, corneal confocal microscopy, NADPH, neuroprotection, obesity
- MeSH terms
- Animals, Blood Glucose, Cornea, Diabetes Mellitus, Experimental, Diabetic Neuropathies, Hypoglycemic Agents, Insulin, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Niacinamide, Obesity, Prediabetic State, Pyridinium Compounds, Streptozocin, Mice, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.